EUVIMEDEUVIMED entdecken
Crossref

Organic‐Platinum Hybrids for Covalent Binding of G‐Quadruplexes: Structural Basis and Application to Cancer Immunotherapy

Liu-Yi Liu iD, Tian-Zhu Ma, You-Liang Zeng, Wenting Liu, Hang Zhang, Zong-Wan Mao iD

Angewandte Chemie International Edition · 2023

DOI: 10.1002/anie.202305645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2023. Verfasst von Liu-Yi Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, IGCME, Sun Yat-Sen University, Guangzhou, 510275, P. R. China. Hauptthemen laut MEDLINE: G-Quadruplexes, Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G‐quadruplexes (G4s) have been revived as promising therapeutic targets with the development of immunotherapy, but the G4‐mediated immune response remains unclear. We designed a novel class of G4‐binding organic‐platinum hybrids, L 1 ‐cispt and L 1 ‐transpt , with spatial matching for G4 binding and G4 DNA reactivity for binding site locking. The solution structure of L 1 ‐transpt ‐MYT1L G4 demonstrated the effectiveness of the covalent binding and revealed the covalent binding‐guided dynamic balance, accompanied by the destruction of the A5‐T17 base pairs to achieve the covalent binding of the platinum unit to N7 of the G6 residue. Furthermore, L 1 ‐cispt‐ and L 1 ‐transpt‐ mediated genomic dysfunction could activate the retinoic acid‐induced gene I (RIG‐I) pathway and induce immunogenic cell death (ICD). The use of L 1 ‐cispt/L 1 ‐transpt‐ treated dying cells as therapeutic vaccines stimulated a robust immune response and effectively inhibited tumor growth in vivo. Our findings highlight the importance of the rational combination of specific spatial recognition and covalent locking in G4‐trageting drug design and their potential in immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

G-QuadruplexesNeoplasmsPlatinumBinding SitesPromoter Regions, GeneticImmunotherapyLigands

Stichwörter der Autor:innen

Cancer ImmunotherapyCovalent BindingG-QuadruplexOrganic-Platinum HybridsSolution Structure

Substanzen

PlatinumLigands

Autor:innen und Institutionen

  • MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, IGCME, Sun Yat-Sen University, Guangzhou, 510275, P. R. China.

ORCID-Profile: Liu-Yi Liu, Zong-Wan Mao

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Liu, L. Y., Ma, T. Z., Zeng, Y. L., Liu, W., Zhang, H., & Mao, Z. W. (2023). Organic‐Platinum Hybrids for Covalent Binding of G‐Quadruplexes: Structural Basis and Application to Cancer Immunotherapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202305645

Vancouver

Liu LY, Ma TZ, Zeng YL, Liu W, Zhang H, Mao ZW. Organic‐Platinum Hybrids for Covalent Binding of G‐Quadruplexes: Structural Basis and Application to Cancer Immunotherapy. Angewandte Chemie International Edition. 2023. doi:10.1002/anie.202305645

BibTeX
@article{Liu2023,
  author = {Liu, Liu-Yi and Ma, Tian-Zhu and Zeng, You-Liang and Liu, Wenting and Zhang, Hang and Mao, Zong-Wan},
  title = {Organic‐Platinum Hybrids for Covalent Binding of G‐Quadruplexes: Structural Basis and Application to Cancer Immunotherapy},
  journal = {Angewandte Chemie International Edition},
  year = {2023},
  doi = {10.1002/anie.202305645}
}
Kostenlos starten →